Articles

Find an Article

Filter articles

Applied Filters

Showing 761 to 770 of 932 results

US Patent Law changes appear imminent

US01-05-2011BiotechnologyJohn Pegram and Mark Ellinger

US patent reform looks like it may finally be coming. John Pegram and Mark Ellinger explain the proposed changes.

Patenting genes and diagnostics

US01-05-2011BiotechnologySimon O’Brien and David Gass

As biotechnology patents continue to grow in importance, uncertainty remains on both sides of the Atlantic as to exactly what is patentable. Simon O’Brien and David Gass take a look.

Attacking the validity of selection patents

Canada01-05-2011Katie Wang

The Canadian Federal Court of Appeal recently considered whether ‘invalid selection’ can be an independent ground for invalidating selection patents. Katie Wang looks at the implications.

The role of the function of DNA sequence before and after grant

EPO, EU01-05-2011Caroline Pallard and Bart Swinkels

Recent European decisions have provided much to think about for practitioners concerned with DNA sequences. Caroline Pallard and Bart Swinkels investigate.

The Brazilian pharmaceutical sector: a year in review

01-05-2011Otto Licks and Anderson Nascimento

Practitioners can take heart from recent developments in the Brazilian courts, say Otto Licks and Anderson Nascimento.

Patentability of dosage regimens in Europe

EPO01-05-2011Stéphane Agasse

First instance courts in France have adopted controversial interpretations of an important Enlarged Board of Appeal decision, says Stéphane Agasse.

Recognising equivalence, reciprocity and respect

Canada, Mexico, US01-05-2011Hedwig Lindner and Manuel Morante

Homologation (recognition of equivalence) is a useful tool for simplifying administrative processes that are repeated in different countries. Nevertheless, it is not an end in itself.

Windows of opportunity and closing doors at the EPO

EPO, EU01-05-2011Claire Baldock

There is a general acceptance that European patent law is complicated, particularly in the area of pharmaceutical inventions. Claire Baldock looks at how the EPO approaches these inventions and the positives and negatives for the pharmaceutical industry.

Crime and punishment: IP sanctions and deterrence

China, US01-04-2011

In the last two decades or so, the notion of categorising certain types of IP infringement as criminal has come into the mainstream. Many countries are now able to impose criminal fines and even jail sentences on the worst offenders.

An interview with Soowon Lee

South Korea01-04-2011

South Korea has developed into a world-class exporter and economic powerhouse. Then the financial crisis struck. WIPR talks to Soowon Lee, commissioner of KIPO, about the role of innovation in an economic recovery and the business of IP.

Showing 761 to 770 of 932 results

Directory

Service Providers

Park IP Translations
Park IP is your trusted partner for legal language solutions

WIPR